Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intermittent vemurafenib therapy in malignant melanoma.
Treiber N, Huber MA, Schneider LA, Scharffetter-Kochanek K, Schultz E, Debus D. Treiber N, et al. Among authors: debus d. J Dtsch Dermatol Ges. 2017 Apr;15(4):451-454. doi: 10.1111/ddg.13034. Epub 2017 Mar 15. J Dtsch Dermatol Ges. 2017. PMID: 28294514 No abstract available.
Intervalltherapie mit Vemurafenib beim malignen Melanom.
Treiber N, Huber MA, Schneider LA, Scharffetter-Kochanek K, Schultz E, Debus D. Treiber N, et al. Among authors: debus d. J Dtsch Dermatol Ges. 2017 Apr;15(4):450-453. doi: 10.1111/ddg.13034_g. J Dtsch Dermatol Ges. 2017. PMID: 28378474 No abstract available.
[Malignant melanoma - from diagnosis to follow-up care].
Krieter M, Schultz E, Debus D. Krieter M, et al. Among authors: debus d. MMW Fortschr Med. 2019 May;161(10):42-50. doi: 10.1007/s15006-019-0018-6. MMW Fortschr Med. 2019. PMID: 31129855 Review. German. No abstract available.
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
Steeb T, Wessely A, Alter M, Bayerl C, Bender A, Bruning G, Dabrowski E, Debus D, Devereux N, Dippel E, Drexler K, Dücker P, Dummer R, Emmert S, Elsner P, Enk A, Gebhardt C, Gesierich A, Goebeler M, Goerdt S, Goetze S, Gutzmer R, Haferkamp S, Hansel G, Hassel JC, Heinzerling L, Kähler KC, Kaume KM, Krapf W, Kreuzberg N, Lehmann P, Livingstone E, Löffler H, Loquai C, Mauch C, Mangana J, Meier F, Meissner M, Moritz RKC, Maul LV, Müller V, Mohr P, Navarini A, Van Nguyen A, Pfeiffer C, Pföhler C, Posch C, Richtig E, Rompel R, Sachse MM, Sauder S, Schadendorf D, Schatton K, Schulze HJ, Schultz E, Schilling B, Schmuth M, Simon JC, Streit M, Terheyden P, Thiem A, Tüting T, Welzel J, Weyandt G, Wesselmann U, Wollina U, Ziemer M, Zimmer L, Zutt M, Berking C, Schlaak M, Heppt MV; German Dermatologic Cooperative Oncology Group (DeCOG, committee ocular melanoma). Steeb T, et al. Among authors: debus d. J Cancer Res Clin Oncol. 2021 Jun;147(6):1763-1771. doi: 10.1007/s00432-020-03450-0. Epub 2020 Nov 21. J Cancer Res Clin Oncol. 2021. PMID: 33219855 Free PMC article.
A prospective observational safety study of patients with BRAFV 600 -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study).
Corrie PG, Terheyden P, Ten Tije AJ, Herbst R, Jansen R, Marples M, Debus D, Marconcini R, Blasinska-Morawiec M, Freivogel K, Munson MLG, Goodman GR, Hsu JJ, Sadetsky N, Colburn D, Rutkowski P. Corrie PG, et al. Among authors: debus d. Br J Dermatol. 2019 May;180(5):1254-1255. doi: 10.1111/bjd.17465. Epub 2019 Feb 10. Br J Dermatol. 2019. PMID: 30488430 No abstract available.
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.
Kreft S, Glutsch V, Zaremba A, Schummer P, Mohr P, Grimmelmann I, Gutzmer R, Meier F, Pföhler C, Sachse MM, Meiss F, Forschner A, Haferkamp S, Welzel J, Terheyden P, Herbst R, Utikal J, Kaatz M, Weishaupt C, Kreuter A, Debus D, Duecker P, Sindrilaru A, Löffler H, Schley G, Weichenthal M, Schadendorf D, Ugurel S, Gesierich A, Schilling B. Kreft S, et al. Among authors: debus d. Eur J Cancer. 2022 May;167:32-41. doi: 10.1016/j.ejca.2022.02.023. Epub 2022 Mar 30. Eur J Cancer. 2022. PMID: 35366571 Free article.
31 results